...
"PASADENA, Calif., September 01, 2022--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:European Respiratory Society (ERS) International Congress 2022 – September 4-6, 2022Title: Silencing MMP7 expression with a lung-targeted RNAi molecule limits fibrosis and preserves pulmonary function in bleomycin-injured ratsPresenter: Erik Bush, Ph.D., Group Vice President, Biology, Arrowhead Pharmaceuticals".
https://au.finance.yahoo.com/news/arrowhead-pharmaceuticals-participate-upcoming-september-113000582.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAJY0c6cs7v1EF8wbubC1ABUqc8xmguOuqo0xyPrSDo1Yy9cmi8ykujeD12z0F1It0l8z1zWkV3vDmvzK_9Epu2r_MYfqHY9q_VKH9eU6hhoBAC0VKqmixJMeFp5K8LtmI3NOqu6c1sIrTl0NEe0txD69Y26fZ0t_FIDYo7HVBFxL
https://www.ersnet.org/congress-and-events/congress/
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Grants Option to Consumer Health Division of Sanofi
Ann: ResApp Grants Option to Consumer Health Division of Sanofi, page-265
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online